EATG » CHMP recommends for approval a generic version of atazanavir

CHMP recommends for approval a generic version of atazanavir

At its January meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of atazanavir – Atazanavir Krka for the treatment of HIV infection.

Summary of opinion for Atazanavir Krka is available here.


 

Source:
EMA
News categories: HIV treatment, EMA/FDA